STOCK TITAN

TD Bank reports 4.9% UroGen Pharma (URGN) share ownership

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

The Toronto-Dominion Bank filed an amended Schedule 13G showing a passive ownership position in UroGen Pharma Ltd. as of 12/31/2025. The bank reports beneficial ownership of 2,302,334 ordinary shares, representing 4.9% of the outstanding class.

TD Bank has sole voting and dispositive power over all reported shares and no shared power. It certifies the shares were acquired and are held in the ordinary course of business, not to change or influence control of UroGen Pharma.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



The Toronto-Dominion Bank
Signature:Christina Petrou
Name/Title:Christina Petrou / Executive Vice President & Chief Operating Officer
Date:02/13/2026
Urogen Pharma

NASDAQ:URGN

URGN Rankings

URGN Latest News

URGN Latest SEC Filings

URGN Stock Data

989.54M
44.31M
6.87%
98.61%
15.17%
Biotechnology
Pharmaceutical Preparations
Link
United States
RA'ANANA